Internal Medicine · Huntington Beach, CA
NPI
1255301024
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
17822 Beach Blvd, #430
Huntington Beach, CA, 92647
Phone (714) 843-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$768K
10,746 services
Medicare patients, 2024
599
Average age 74
Drug cost, 2024
$1.4M
14,476 prescriptions
Company payments, 2025
$1,502
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Nassir was code 99233 (hospital e&m - subsequent), 1,436 times for 169 patients. In total Joseph Nassir billed 10,746 services in 59 codes, and Medicare paid $768K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,436 | 169 | $97.36 | $140K |
| 99309 SNF E&M | Facility | 1,389 | 128 | $88.96 | $124K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,239 | 155 | $52.29 | $65K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,093 | 148 | $41.05 | $45K |
| 99213 Office E&M - Established | Office | 809 | 269 | $71.19 | $58K |
| 99214 Office E&M - Established | Office | 645 | 240 | $99.38 | $64K |
| 99457 E&M - Miscellaneous | Office | 457 | 76 | $42.48 | $19K |
| 99458 E&M - Miscellaneous | Office | 412 | 71 | $33.70 | $14K |
| 99454 E&M - Miscellaneous | Office | 369 | 73 | $43.96 | $16K |
| 99223 Hospital E&M - Initial | Facility | 234 | 174 | $141.81 | $33K |
| 99291 Critical Care E&M | Facility | 211 | 23 | $172.16 | $36K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 207 | 92 | $84.37 | $17K |
| 99497 Care Management/Coordination | Office | 199 | 193 | $70.85 | $14K |
| 96372 Injection Administration | Office | 178 | 73 | $11.78 | $2,097 |
| 36415 Venipuncture Blood Collection | Office | 178 | 134 | $8.65 | $1,540 |
By year: 2022 $492K for 6,881 services; 2023 $638K for 10,026 services; 2024 $768K for 10,746 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 178 | 134 | $8.65 | $1,540 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Nassir prescribed most often to Medicare patients was Atorvastatin Calcium, with 760 prescriptions and refills. In total Joseph Nassir wrote 14,476 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 760 | 1,670 | 200 | $7,304 |
| Levothyroxine Sodium Generic | 536 | 1,198 | 125 | $6,044 |
| Amlodipine Besylate Generic | 478 | 1,043 | 117 | $2,634 |
| Pantoprazole Sodium Generic | 384 | 715 | 109 | $9,034 |
| Furosemide Generic | 361 | 591 | 82 | $2,082 |
| Gabapentin Generic | 358 | 507 | 79 | $7,525 |
| Losartan Potassium Generic | 304 | 702 | 74 | $3,630 |
| Tamsulosin Hcl Generic | 226 | 512 | 70 | $3,378 |
| Rosuvastatin Calcium Generic | 222 | 540 | 60 | $3,021 |
| Fluticasone Propionate Generic | 217 | 318 | 93 | $3,362 |
| Eliquis Apixaban | 215 | 258 | 50 | $114K |
| Metformin Hcl Generic | 214 | 448 | 51 | $1,698 |
| Tramadol Hcl Generic | 204 | 204 | 45 | $1,513 |
| Potassium Chloride Generic | 201 | 320 | 45 | $3,788 |
| Alendronate Sodium Generic | 198 | 474 | 51 | $1,499 |
Brand drugs: 1,986 claims; generic drugs: 12,363 claims; opioid claims: 442.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Nassir $1,502 ($1,502 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $488.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 21 | $488 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $201 |
| Lundbeck LLC | 6 | $110 |
| Abbvie Inc. ABBV | 3 | $91.47 |
| Amgen Inc. AMGN | 4 | $79.67 |
| Lilly USA, LLC LLY | 4 | $74.35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66.02 |
| Novo Nordisk Inc NVO | 2 | $47.08 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $46.48 |
| Paratek Pharmaceuticals, Inc. | 2 | $42.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.